The results of the present study indicated that the METTL3/miR-335/Erf1 axis contributed to SG formation in the early stage of AIS, which may enable the development of new therapeutic strategies for the prevention and treatment of the early stage of the disease. This evidence concerns the gene ETF1 and androgen insensitivity syndrome.